Crónicas de autores

Manuel Vázquez Carrera *

Autor invitado por SIIC

El trabajo destaca que los ácidos grasos libres pueden producir algunos de sus efectos prodiabéticos a través de la inducción de IL-6

EL ACIDO PALMITICO AUMENTA LA EXPRESION DE INTERLEUCINA 6 EN CELULAS MUSCULARES ESQUELETICAS

Los resultados de este estudio sugieren que la IL-6 puede mediar parte de los efectos del palmitato sobre la sensibilidad a la insulina.

*Manuel Vázquez Carrera
describe para SIIC los aspectos relevantes de su trabajo
PALMITATE-INDUCED INTERLEUKIN 6 PRODUCTION IS MEDIATED BY PROTEIN KINASE C AND NUCLEAR-FACTOR KAPPAB ACTIVATION AND LEADS TO GLUCOSE TRANSPORTER 4 DOWN-REGULATION IN SKELETAL MUSCLE CELLS
Endocrinology,
146(7):3087-3095 Jul, 2005

Esta revista, clasificada por SIIC Data Bases, integra el acervo bibliográfico
de la Biblioteca Biomédica (BB) SIIC.

Institución principal de la investigación
*Unidad de Farmacología, Facultad de Farmacia, Universidad de Barcelona, Barcelona, España, Barcelona, España
Profundizar
Imprimir nota
Comprar este artículo
Otros artículos escogidos
Referencias bibliográficas
1. DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991; 14:173-194.
2. Boden G, Jadali F, White J, Liang Y, Mozzoli M, Chen X et al. Effects of fat on insulin-stimulated carbohydrate-metabolism in normal men. Journal of Clinical Investigation 1991; 88:960-966.
3. Boden G, Chen XH. Effects of fat on glucose-uptake and utilization in patients with non-insulin-dependent diabetes. Journal of Clinical Investigation 1995; 96:1261-1268.
4. Roden M, Price TB, Perseghin G, Petersen KF, Rothman DL, Cline GW et.al. Mechanism of free fatty acid-induced insulin resistance in humans. Journal of Clinical Investigation 1996;97:2859-2865.
5. Boden G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 1997; 46:3-10.
6. Bronfman M, Morales MN, Orellana A. Diacylglycerol activation of protein kinase-C is modulated by long-chain acyl-CoA. Biochemical and Biophysical Research Communications 1988; 152:987-992.
7. Nishizuka Y. Protein kinases 5. Protein-kinase-C and lipid signaling for sustained cellular-responses. Faseb Journal 1995; 9:484-496.
8. Schmitz Peiffer C, Browne CL, Oakes ND, Watkinson A, Chisholm DJ, Kraegen EW et al. Alterations in the expression and cellular localization of protein kinase C isozymes epsilon and theta are associated with insulin resistance in skeletal muscle of the high-fat-fed rat. Diabetes 1997; 46:169-178.
9. Ruderman NB, Saha AK, Vavvas D, Witters LA. Malonyl-CoA, fuel sensing, and insulin resistance. American Journal of Physiology-Endocrinology and Metabolism 1999; 276:E1-E18.
10. Heydrick SJ, Ruderman NB, Kurowski TG, Adams HB, Chen KS. Enhanced stimulation of diacylglycerol and lipid-synthesis by insulin in denervated muscle - altered protein-kinase-C activity and possible link to insulin resistance. Diabetes 1991; 40:1707-1711.
11. Griffin ME, Marcucci MJ, Cline GW, Bell K, Barucci N, Lee D et al. Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes 1999; 48:1270-1274.
12. Cortright RN, Azevedo JL, Zhou Q, Sinha M, Pories WJ, Itani SI et.al. Protein kinase C modulates insulin action in human skeletal muscle. American Journal of Physiology-Endocrinology and Metabolism 2000; 278:E553-E562.
13. Itani SI, Zhou Q, Pories WJ, MacDonald KG, Dohm GL. Involvement of protein kinase C in human skeletal muscle insulin resistance and obesity. Diabetes 2000; 49:1353-1358.
14. Chavez JA, Knotts TA, Wang LP, Li G, Dobrowsky RT, Florant GL et al. A role for ceramide, but not diacylglycerol, in the antagonism of insulin signal transduction by saturated fatty acids. J Biol Chem 2003; 278:10297-10303.
15. Pickup JC, Mattock MB, Chusney GD, Burt D. NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia 1997; 40:1286-1292.
16. Kern PA, Ranganathan S, Li CL, Wood L, Ranganathan G. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. American Journal of Physiology-Endocrinology and Metabolism 2001; 280:E745-E751.
17. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001; 286:327-334.
18. Starkie RL, Arkinstall MJ, Koukoulas I, Hawley JA, Febbraio MA. Carbohydrate ingestion attenuates the increase in plasma interleukin-6, but not skeletal muscle interleukin-6 mRNA, during exercise in humans. Journal of Physiology 2001; 533:585-591.
19. Pedersen BK, Steensberg A, Fischer C, Keller C, Ostrowski K, Schjerling P. Exercise and cytokines with particular focus on muscle-derived IL-6. Exercise Immunology Review 2001; 7:18-31.
20. Carey AL, Lamont B, Andrikopoulos S, Koukoulas I, Proietto J, Febbraio MA. Interleukin-6 gene expression is increased in insulin-resistant rat skeletal muscle following insulin stimulation. Biochemical and Biophysical Research Communications 2003; 302:837-840.
21. Kosmidou I, Vassilakopoulos T, Xagorari A, Zakynthinos S, Papapetropoulos A, Roussos C. Production of interleukin-6 by skeletal myotubes - Role of reactive oxygen species. American Journal of Respiratory Cell and Molecular Biology 2002; 26:587-593.
22. Frost RA, Nystrom GJ, Lang CH. Lipopolysaccharide regulates proinflammatory cytokine expression in mouse myoblasts and skeletal muscle. American Journal of Physiology-Regulatory Integrative and Comparative Physiology 2002; 283:R698-R709.
23. Febbraio MA, Pedersen BK. Muscle-derived interleukin-6: mechanisms for activation and possible biological roles. Faseb Journal 2002; 16:1335-1347.
24. Chavez JA, Knotts TA, Wang LP, Li GB, Dobrowsky RT, Florant GL et al. A role for ceramide, but not diacylglycerol, in the antagonism of insulin signal transduction by saturated fatty acids. Journal of Biological Chemistry 2003; 278:10297-10303.
25. Cabrero A, Alegret M, Sánchez RM, Adzet T, Laguna JC, Carrera MV. Increased reactive oxygen species production down-regulates peroxisome proliferator-activated alpha pathway in C2C12 skeletal muscle cells. Journal of Biological Chemistry 2002; 277:10100-10107.
26. Freeman WM, Walker SJ, Vrana KE. Quantitative RT-PCR: pitfalls and potential. Biotechniques 1999; 26:112-115.
27. Andrews NC, Faller DV. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian-cells. Nucleic Acids Research 1991; 19:2499-2499.
28. Gorski J, Nawrocki A, Murthy M. Characterization of free and glyceride-esterified long chain fatty acids in different skeletal muscle types of the rat. Molecular and Cellular Biochemistry 1998; 178:113-118.
29. Paumen MB, Ishida Y, Muramatsu M, Yamamoto M, Honjo T. Inhibition of carnitine palmitoyltransferase I augments sphingolipid synthesis and palmitate-induced apoptosis. Journal of Biological Chemistry 1997; 272:3324-3329.
30. Miyake Y, Kozutsumi Y, Nakamura S, Fujita T, Kawasaki T. Serine palmitoyltransferase is the primary target of a sphingosine-like immunosuppressant, Isp-1/myriocin. Biochemical and Biophysical Research Communications 1995; 211:396-403.
31. Poynter ME, Daynes RA. Peroxisome proliferator-activated receptor alpha activation modulates cellular redox status, represses nuclear factor kappa B signaling, and reduces inflammatory cytokine production in aging. Journal of Biological Chemistry 1998; 273:32833-32841.
32. Kim JK, Kim YJ, Fillmore JJ, Chen Y, Moore I, Lee JS et al. Prevention of fat-induced insulin resistance by salicylate. Journal of Clinical Investigation 2001; 108:437-446.
33. Kobayashi E, Ando K, Nakano H, Iida T, Ohno H, Morimoto M et al. Calphostins (Ucn-1028), novel and specific inhibitors of protein kinase-C. 1. Fermentation, isolation, physicochemical properties and biological-activities. Journal of Antibiotics 1989; 42:1470-1474.
34. Sanders JL, Stern PH. Expression and phorbol ester sensitivity of protein kinase C (PKC) isozymes in osteoblasts. Faseb Journal 1996; 10:3923-3923.
35. Bordin L, Priante G, Musacchio E, Giunco S, Tibaldi E, Clari G et al. Arachidonic acid-induced IL-6 expression is mediated by PKC alpha activation in osteoblastic cells. Biochemistry 2003; 42:4485-4491.
36. Ravichandran LV, Esposito DL, Chen J, Quon MJ. Protein kinase C-zeta phosphorylates insulin receptor substrate-1 and impairs its ability to activate phosphatidylinositol 3-kinase in response to insulin. Journal of Biological Chemistry 2001; 276:3543-3549.
37. Lagathu C, Bastard JP, Auclair M, Maachi M, Capeau J, Caron M. Chronic interleukin-6 (IL-6) treatment increased IL-6 secretion and induced insulin resistance in adipocyte: prevention by rosiglitazone. Biochemical and Biophysical Research Communications 2003; 311:372-379.
38. Rotter V, Nagaev I, Smith U. Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects. Journal of Biological Chemistry 2003; 278:45777-45784.
39. Senn JJ, Klover PJ, Nowak IA, Mooney RA. Interleukin-6 induces cellular insulin resistance in hepatocytes. Diabetes 2002; 51:3391-3399.
40. Klover PJ, Zimmers TA, Koniaris LG, Mooney RA. Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice. Diabetes 2003; 52:2784-2789.
41. Senn JJ, Klover PJ, Noway I, Furlanetto IR, Mooney RA. Suppressor of cytokine signaling-3 (SOCS-3) is a potential mediator of interleukin-6 dependent insulin resistance. Diabetes 2002; 51:A324-A324.
42. Gauthier Rouviere C, Vandromme M, Tuil D, Lautredou N, Morris M, Soulez M et al. Expression and activity of serum response factor is required for expression of the muscle-determining factor MyoD in both dividing and differentiating mouse C2C12 myoblasts. Molecular Biology of the Cell 1996; 7:719-729.
43. Chin JE, Dickens M, Tavare JM, Roth RA. Overexpression of protein-kinase-C isoenzymes-alpha, beta-I, gamma, and epsilon in cells overexpressing the insulin-receptor - Effects on receptor phosphorylation and signaling. Journal of Biological Chemistry 1993; 268:6338-6347.
44. Itani SI, Ruderman NB, Schmieder F, Boden G. Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and I kappa B-alpha. Diabetes 2002; 51:2005-2011.
45. Ghosh S, Baltimore D. Activation in vitro of Nf-kappa-B by phosphorylation of its inhibitor I-kappa-B. Nature 1990; 344:678-682.


ua40317
Home

Copyright siicsalud © 1997-2024 ISSN siicsalud: 1667-9008